Treatment group

(n = 11)

Control

(n = 5)

P value

Age

74

58

0.33

Sex (male)

5

4

0.44

Disease duration (years)

8.5

5.8

0.22

Height (cm)

154

166

0.01

Weight (kg)

44

61

0.001

BMI

18.8

21.1

0.009

Hoehn and Yahr stage (on)

3.5

2.4

0.019

UPDRS I

5.4

1.8

0.003

UPDRS II

15.7

6.4

0.001

UPDRS III

25.5

9.8

0.003

UPDRS IV

2.5

1

0.15

MIBG early

1.66

1.60

0.41

MIBG delay

1.43

1.38

0.80

Medication

Carbidopa-Levodopa (mg)

482

320

Entacapone (mg)

450 (n = 2)

Pramipexole hydrochloride

hydrate (mg)

1.5 (n = 3)

1.6 (n = 4)

Ropinirole hydrochloride (mg)

12.2 (n = 6)

Selegiline hydrochloride (mg)

4.2 (n = 2)

5 (n = 1)

Amantadine hydrochloride (mg)

130 (n = 2)

100 (n = 1)

Zonisamide (mg)

25 (n = 3)